Global framework on essential health R&D

被引：106

作者：

Chirac, P ^{[1
]}

Torreele, E

机构：

[1] Med Sans Frontieres, F-75544 Paris 11, France

[2] Drugs Neglected Dis Initiat, Geneva, Switzerland

来源：

LANCET | 2006年 / 367卷 / 9522期

关键词：

D O I：

10.1016/S0140-6736(06)68672-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1560 / 1561

页数：2

共 12 条

[1]

ARRAL PE, 2005, 30 ANS RESULTATS REC

[2]

*DNDI, 2006, NEW HOP MAL PAT 2006

[3]

Moran M., 2005, NEW LANDSCAPE NEGLEC

[4] Access to essential drugs in poor countries -: A lost battle? [J].

Pécoul, B ;

Chirac, P ;

Trouiller, P ;

Pinel, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (04) :361-367

[5]

Trouiller P, 1998, Int J Infect Dis, V3, P61, DOI 10.1016/S1201-9712(99)90010-3

[6] Drug development for neglected diseases: a deficient market and a public-health policy failure [J].

Trouiller, P ;

Olliaro, P ;

Torreele, E ;

Orbinski, J ;

Laing, R ;

Ford, N .

LANCET, 2002, 359 (9324) :2188-2194

[7]

*WHO, 2005, PUBL HLTH INN INT PR

[8]

*WHO, 2002, MILT STOR SUCC PARTN

[9]

*WHO, 2000, DUTCH REG ART INJ

[10]

*WHO, 2001, ART SULPH PYRIM COMB

← 1 2 →